**
Bristol Myers Squibb is seeking a Senior Institutional Mental Health Account Specialist for their Neuroscience division, focused on the commercialization of COBENFY, a new treatment for schizophrenia. The position is field-based, requiring engagement with healthcare providers at various community mental health centers and hospitals, emphasizing scientific dialogue and customer experience.
**
Job Summary
This role is critical for the US commercialization of COBENFY, the first treatment targeting muscarinic receptor circuits for schizophrenia.
The position requires engaging healthcare providers at Community Mental Health Centers, Certified Community Behavior Health Centers, and Hospitals to drive product adoption.
Bristol Myers Squibb offers competitive benefits including flexible time off, comprehensive health coverage, and a 401(k) plan.
Matching Summary
Match Score: 75
**
Bristol Myers Squibb is seeking a Senior Institutional Mental Health Account Specialist for their Neuroscience division, focused on the commercialization of COBENFY, a new treatment for schizophrenia. The position is field-based, requiring engagement with healthcare providers at various community mental health centers and hospitals, emphasizing scientific dialogue and customer experience.
**
Salary
Base: $139,230 - $168,714; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Medical, dental, vision, 401(k), paid time off
Skills & Requirements
Must-have
5+ years pharmaceutical sales experience
Field-based role with 100% travel
Experience with Community Mental Health Centers
Knowledge of P&T committee processes
Proven track record meeting sales targets
Nice-to-have
Prior experience in Psychiatry therapeutic area
Strong cross-functional collaboration skills
Patient-centric mindset and agility
Ability to articulate complex clinical data
Key Requirements
Advanced scientific degree or 5+ years pharma experience
Valid driver's license and acceptable driving risk level
Minimum age of 21 years old
Demonstrated understanding of hospital treatment pathways